Barrington Research Reiterates “Outperform” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a research note issued to investors on Friday, Benzinga reports. They currently have a $36.00 price target on the medical instruments supplier’s stock. Barrington Research’s price target indicates a potential upside of 36.67% from the company’s previous close.

Several other brokerages have also weighed in on XRAY. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Needham & Company LLC reissued a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Finally, Stifel Nicolaus cut their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $33.22.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.56 during trading hours on Friday, reaching $26.34. 280,775 shares of the stock were exchanged, compared to its average volume of 3,081,437. DENTSPLY SIRONA has a 52-week low of $23.58 and a 52-week high of $37.60. The stock has a market cap of $5.34 billion, a P/E ratio of -59.86, a P/E/G ratio of 1.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The firm’s 50 day moving average is $25.54 and its 200 day moving average is $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the previous year, the firm posted $0.51 EPS. The business’s revenue for the quarter was down 4.3% on a year-over-year basis. Analysts predict that DENTSPLY SIRONA will post 1.99 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in the business. Principal Securities Inc. acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth about $26,000. LRI Investments LLC lifted its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $32,000. Central Pacific Bank Trust Division bought a new position in DENTSPLY SIRONA during the 1st quarter worth approximately $64,000. Finally, Mather Group LLC. acquired a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $72,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.